GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Croma NV (XAMS:EHCS) » Definitions » Accounts Receivable

Croma NV (XAMS:EHCS) Accounts Receivable : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Croma NV Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Croma NV's accounts receivables for the quarter that ended in Dec. 2023 was €0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Croma NV's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was €-1.62.


Croma NV Accounts Receivable Historical Data

The historical data trend for Croma NV's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Croma NV Accounts Receivable Chart

Croma NV Annual Data
Trend Dec21 Dec22 Dec23
Accounts Receivable
- - -

Croma NV Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Receivable - - - - -

Croma NV Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Croma NV Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Croma NV's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Croma NV's accounts receivable are only considered to be worth 75% of book value:

Croma NV's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.21+0.75 * 0+0.5 * 0-13.983
-0-0)/7.90563
=-1.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Croma NV Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Croma NV's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Croma NV (XAMS:EHCS) Business Description

Traded in Other Exchanges
Address
c/o ALR Treuhand GmbH Theresienhohe 28, Munich, BY, DEU, 80338
European Healthcare Acquisition Growth Co BV is a special purpose acquisition company aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.

Croma NV (XAMS:EHCS) Headlines

No Headlines